The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Status:
Completed

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

The purpose of this study is to investigate effects of inhaled AZD8683 compared to placebo in COPD patients.

Phase 2

AstraZeneca